Exactly. That was a HORRIBLE SELL. Lol. Should have taken advantage of the dip from $1.68 to anything under $3. Oppenheimer releases that a few weeks before FDA approval and the warrants were already done in November. They did that to load up one last time, as we are about 2 weeks away from FDA approval and updates. Watch last years chart. We are heading back to $7 this quarter and possibly higher with guidance, new CEO, and always potential buyout.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.